0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nucleic Acid Based Gene Therapy Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-24P13243
Home | Market Reports | Science| Biological Sciences
Global Nucleic Acid Based Gene Therapy Market Research Report 2023
BUY CHAPTERS

Global Nucleic Acid Based Gene Therapy Market Research Report 2025

Code: QYRE-Auto-24P13243
Report
February 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nucleic Acid Based Gene Therapy Market Size

The global market for Nucleic Acid Based Gene Therapy was valued at US$ 5406 million in the year 2024 and is projected to reach a revised size of US$ 10370 million by 2031, growing at a CAGR of 9.9% during the forecast period.

Nucleic Acid Based Gene Therapy Market

Nucleic Acid Based Gene Therapy Market

Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Based Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Based Gene Therapy.
The Nucleic Acid Based Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid Based Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Based Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nucleic Acid Based Gene Therapy Market Report

Report Metric Details
Report Name Nucleic Acid Based Gene Therapy Market
Accounted market size in year US$ 5406 million
Forecasted market size in 2031 US$ 10370 million
CAGR 9.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals and Clinics
  • Academic and Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Wave Life Sciences, Imugene, Sarepta Therapeutics, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Moderna, BioNTech, Nutcracker Therapeutics, Deep Genomics, Sirnaomics, Laronde, Abogen Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nucleic Acid Based Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nucleic Acid Based Gene Therapy Market growing?

Ans: The Nucleic Acid Based Gene Therapy Market witnessing a CAGR of 9.9% during the forecast period 2025-2031.

What is the Nucleic Acid Based Gene Therapy Market size in 2031?

Ans: The Nucleic Acid Based Gene Therapy Market size in 2031 will be US$ 10370 million.

Who are the main players in the Nucleic Acid Based Gene Therapy Market report?

Ans: The main players in the Nucleic Acid Based Gene Therapy Market are Wave Life Sciences, Imugene, Sarepta Therapeutics, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Moderna, BioNTech, Nutcracker Therapeutics, Deep Genomics, Sirnaomics, Laronde, Abogen Biosciences

What are the Application segmentation covered in the Nucleic Acid Based Gene Therapy Market report?

Ans: The Applications covered in the Nucleic Acid Based Gene Therapy Market report are Hospitals and Clinics, Academic and Research Institutes, Others

What are the Type segmentation covered in the Nucleic Acid Based Gene Therapy Market report?

Ans: The Types covered in the Nucleic Acid Based Gene Therapy Market report are Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Others

Recommended Reports

Gene Therapy Markets

Nucleic Acid Therapeutics

Genetic Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-Sence and Anti-Gene
1.2.3 Short Inhibitory Sequences
1.2.4 Gene Transfer Therapy
1.2.5 Nucleoside Analogs
1.2.6 Ribozymes
1.2.7 Aptamers
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nucleic Acid Based Gene Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Academic and Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Based Gene Therapy Market Perspective (2020-2031)
2.2 Global Nucleic Acid Based Gene Therapy Growth Trends by Region
2.2.1 Global Nucleic Acid Based Gene Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nucleic Acid Based Gene Therapy Historic Market Size by Region (2020-2025)
2.2.3 Nucleic Acid Based Gene Therapy Forecasted Market Size by Region (2026-2031)
2.3 Nucleic Acid Based Gene Therapy Market Dynamics
2.3.1 Nucleic Acid Based Gene Therapy Industry Trends
2.3.2 Nucleic Acid Based Gene Therapy Market Drivers
2.3.3 Nucleic Acid Based Gene Therapy Market Challenges
2.3.4 Nucleic Acid Based Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Based Gene Therapy Players by Revenue
3.1.1 Global Top Nucleic Acid Based Gene Therapy Players by Revenue (2020-2025)
3.1.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nucleic Acid Based Gene Therapy Revenue
3.4 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio
3.4.1 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Based Gene Therapy Revenue in 2024
3.5 Global Key Players of Nucleic Acid Based Gene Therapy Head office and Area Served
3.6 Global Key Players of Nucleic Acid Based Gene Therapy, Product and Application
3.7 Global Key Players of Nucleic Acid Based Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Based Gene Therapy Breakdown Data by Type
4.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Type (2020-2025)
4.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Type (2026-2031)
5 Nucleic Acid Based Gene Therapy Breakdown Data by Application
5.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Application (2020-2025)
5.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nucleic Acid Based Gene Therapy Market Size (2020-2031)
6.2 North America Nucleic Acid Based Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nucleic Acid Based Gene Therapy Market Size by Country (2020-2025)
6.4 North America Nucleic Acid Based Gene Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Based Gene Therapy Market Size (2020-2031)
7.2 Europe Nucleic Acid Based Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2020-2025)
7.4 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size (2020-2031)
8.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Based Gene Therapy Market Size (2020-2031)
9.2 Latin America Nucleic Acid Based Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2020-2025)
9.4 Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size (2020-2031)
10.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Details
11.1.2 Wave Life Sciences Business Overview
11.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Introduction
11.1.4 Wave Life Sciences Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.1.5 Wave Life Sciences Recent Development
11.2 Imugene
11.2.1 Imugene Company Details
11.2.2 Imugene Business Overview
11.2.3 Imugene Nucleic Acid Based Gene Therapy Introduction
11.2.4 Imugene Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.2.5 Imugene Recent Development
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Details
11.3.2 Sarepta Therapeutics Business Overview
11.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.3.4 Sarepta Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.3.5 Sarepta Therapeutics Recent Development
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Details
11.4.2 Alnylam Pharmaceuticals Business Overview
11.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.4.4 Alnylam Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.4.5 Alnylam Pharmaceuticals Recent Development
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Details
11.5.2 Ionis Pharmaceuticals Business Overview
11.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.5.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.5.5 Ionis Pharmaceuticals Recent Development
11.6 Moderna
11.6.1 Moderna Company Details
11.6.2 Moderna Business Overview
11.6.3 Moderna Nucleic Acid Based Gene Therapy Introduction
11.6.4 Moderna Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.6.5 Moderna Recent Development
11.7 BioNTech
11.7.1 BioNTech Company Details
11.7.2 BioNTech Business Overview
11.7.3 BioNTech Nucleic Acid Based Gene Therapy Introduction
11.7.4 BioNTech Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.7.5 BioNTech Recent Development
11.8 Nutcracker Therapeutics
11.8.1 Nutcracker Therapeutics Company Details
11.8.2 Nutcracker Therapeutics Business Overview
11.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.8.4 Nutcracker Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.8.5 Nutcracker Therapeutics Recent Development
11.9 Deep Genomics
11.9.1 Deep Genomics Company Details
11.9.2 Deep Genomics Business Overview
11.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Introduction
11.9.4 Deep Genomics Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.9.5 Deep Genomics Recent Development
11.10 Sirnaomics
11.10.1 Sirnaomics Company Details
11.10.2 Sirnaomics Business Overview
11.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Introduction
11.10.4 Sirnaomics Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.10.5 Sirnaomics Recent Development
11.11 Laronde
11.11.1 Laronde Company Details
11.11.2 Laronde Business Overview
11.11.3 Laronde Nucleic Acid Based Gene Therapy Introduction
11.11.4 Laronde Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.11.5 Laronde Recent Development
11.12 Abogen Biosciences
11.12.1 Abogen Biosciences Company Details
11.12.2 Abogen Biosciences Business Overview
11.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Introduction
11.12.4 Abogen Biosciences Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025)
11.12.5 Abogen Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Anti-Sence and Anti-Gene
 Table 3. Key Players of Short Inhibitory Sequences
 Table 4. Key Players of Gene Transfer Therapy
 Table 5. Key Players of Nucleoside Analogs
 Table 6. Key Players of Ribozymes
 Table 7. Key Players of Aptamers
 Table 8. Key Players of Others
 Table 9. Global Nucleic Acid Based Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Nucleic Acid Based Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Nucleic Acid Based Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Nucleic Acid Based Gene Therapy Market Share by Region (2020-2025)
 Table 13. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Nucleic Acid Based Gene Therapy Market Share by Region (2026-2031)
 Table 15. Nucleic Acid Based Gene Therapy Market Trends
 Table 16. Nucleic Acid Based Gene Therapy Market Drivers
 Table 17. Nucleic Acid Based Gene Therapy Market Challenges
 Table 18. Nucleic Acid Based Gene Therapy Market Restraints
 Table 19. Global Nucleic Acid Based Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Nucleic Acid Based Gene Therapy Market Share by Players (2020-2025)
 Table 21. Global Top Nucleic Acid Based Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2024)
 Table 22. Ranking of Global Top Nucleic Acid Based Gene Therapy Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Nucleic Acid Based Gene Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Nucleic Acid Based Gene Therapy, Headquarters and Area Served
 Table 25. Global Key Players of Nucleic Acid Based Gene Therapy, Product and Application
 Table 26. Global Key Players of Nucleic Acid Based Gene Therapy, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Nucleic Acid Based Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Type (2020-2025)
 Table 30. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Type (2026-2031)
 Table 32. Global Nucleic Acid Based Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Application (2020-2025)
 Table 34. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Application (2026-2031)
 Table 36. North America Nucleic Acid Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Nucleic Acid Based Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Nucleic Acid Based Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Nucleic Acid Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Nucleic Acid Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Wave Life Sciences Company Details
 Table 52. Wave Life Sciences Business Overview
 Table 53. Wave Life Sciences Nucleic Acid Based Gene Therapy Product
 Table 54. Wave Life Sciences Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 55. Wave Life Sciences Recent Development
 Table 56. Imugene Company Details
 Table 57. Imugene Business Overview
 Table 58. Imugene Nucleic Acid Based Gene Therapy Product
 Table 59. Imugene Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 60. Imugene Recent Development
 Table 61. Sarepta Therapeutics Company Details
 Table 62. Sarepta Therapeutics Business Overview
 Table 63. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product
 Table 64. Sarepta Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 65. Sarepta Therapeutics Recent Development
 Table 66. Alnylam Pharmaceuticals Company Details
 Table 67. Alnylam Pharmaceuticals Business Overview
 Table 68. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product
 Table 69. Alnylam Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 70. Alnylam Pharmaceuticals Recent Development
 Table 71. Ionis Pharmaceuticals Company Details
 Table 72. Ionis Pharmaceuticals Business Overview
 Table 73. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product
 Table 74. Ionis Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 75. Ionis Pharmaceuticals Recent Development
 Table 76. Moderna Company Details
 Table 77. Moderna Business Overview
 Table 78. Moderna Nucleic Acid Based Gene Therapy Product
 Table 79. Moderna Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 80. Moderna Recent Development
 Table 81. BioNTech Company Details
 Table 82. BioNTech Business Overview
 Table 83. BioNTech Nucleic Acid Based Gene Therapy Product
 Table 84. BioNTech Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 85. BioNTech Recent Development
 Table 86. Nutcracker Therapeutics Company Details
 Table 87. Nutcracker Therapeutics Business Overview
 Table 88. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product
 Table 89. Nutcracker Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 90. Nutcracker Therapeutics Recent Development
 Table 91. Deep Genomics Company Details
 Table 92. Deep Genomics Business Overview
 Table 93. Deep Genomics Nucleic Acid Based Gene Therapy Product
 Table 94. Deep Genomics Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 95. Deep Genomics Recent Development
 Table 96. Sirnaomics Company Details
 Table 97. Sirnaomics Business Overview
 Table 98. Sirnaomics Nucleic Acid Based Gene Therapy Product
 Table 99. Sirnaomics Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 100. Sirnaomics Recent Development
 Table 101. Laronde Company Details
 Table 102. Laronde Business Overview
 Table 103. Laronde Nucleic Acid Based Gene Therapy Product
 Table 104. Laronde Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 105. Laronde Recent Development
 Table 106. Abogen Biosciences Company Details
 Table 107. Abogen Biosciences Business Overview
 Table 108. Abogen Biosciences Nucleic Acid Based Gene Therapy Product
 Table 109. Abogen Biosciences Revenue in Nucleic Acid Based Gene Therapy Business (2020-2025) & (US$ Million)
 Table 110. Abogen Biosciences Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. Nucleic Acid Based Gene Therapy Picture
 Figure 2. Global Nucleic Acid Based Gene Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nucleic Acid Based Gene Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Anti-Sence and Anti-Gene Features
 Figure 5. Short Inhibitory Sequences Features
 Figure 6. Gene Transfer Therapy Features
 Figure 7. Nucleoside Analogs Features
 Figure 8. Ribozymes Features
 Figure 9. Aptamers Features
 Figure 10. Others Features
 Figure 11. Global Nucleic Acid Based Gene Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Nucleic Acid Based Gene Therapy Market Share by Application: 2024 VS 2031
 Figure 13. Hospitals and Clinics Case Studies
 Figure 14. Academic and Research Institutes Case Studies
 Figure 15. Others Case Studies
 Figure 16. Nucleic Acid Based Gene Therapy Report Years Considered
 Figure 17. Global Nucleic Acid Based Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Nucleic Acid Based Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Nucleic Acid Based Gene Therapy Market Share by Region: 2024 VS 2031
 Figure 20. Global Nucleic Acid Based Gene Therapy Market Share by Players in 2024
 Figure 21. Global Top Nucleic Acid Based Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Nucleic Acid Based Gene Therapy Revenue in 2024
 Figure 23. North America Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Nucleic Acid Based Gene Therapy Market Share by Country (2020-2031)
 Figure 25. United States Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Nucleic Acid Based Gene Therapy Market Share by Country (2020-2031)
 Figure 29. Germany Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Nucleic Acid Based Gene Therapy Market Share by Region (2020-2031)
 Figure 37. China Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Nucleic Acid Based Gene Therapy Market Share by Country (2020-2031)
 Figure 45. Mexico Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Nucleic Acid Based Gene Therapy Market Share by Country (2020-2031)
 Figure 49. Turkey Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Nucleic Acid Based Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Wave Life Sciences Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 53. Imugene Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 54. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 55. Alnylam Pharmaceuticals Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 56. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 57. Moderna Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 58. BioNTech Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 59. Nutcracker Therapeutics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 60. Deep Genomics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 61. Sirnaomics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 62. Laronde Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 63. Abogen Biosciences Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart